Individual medicine in inflammatory bowel disease: monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies
Klaus Bendtzen, Mark Ainsworth, Casper Steenholdt, Ole Østergaard Thomsen, Jørn Brynskov, Klaus Bendtzen, Mark Ainsworth, Casper Steenholdt, Ole Østergaard Thomsen, Jørn Brynskov
126Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Individual medicine in inflammatory bowel disease: monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies'. Together they form a unique fingerprint.